rcca-header
Articles/News – In the News

Take Five with Terrill Jordan

Terrill Jordan is President and CEO of Regional Cancer Care Associates (RCCA). He spoke to Symptoms & Cures about RCCA’s move toward value-based care in the field of cancer treatment.

CMS announces that RCCA has been selected for initiative promoting better cancer care

The Centers for Medicare & Medicaid Services (CMS) has announced that it has selected Regional Cancer Care Associates LLC (RCCA) as one of nearly 200 physician group practices and 17 health insurance companies to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. The Medicare arm of the Oncology Care Model includes more than 3,200 oncologists and will cover approximately 155,000 Medicare beneficiaries nationwide.

RCCA and Osler Health join forces to provide cancer care using collaborative physician teams

Regional Cancer Care Associates LLC (RCCA) and Osler Health have partnered up to deliver higher-quality and higher-efficiency integrated cancer care to New Jersey. RCCA is New Jersey’s largest cancer care physician’s group, and Osler Health is one of New Jersey’s largest next-generation patient-centered physician networks. Together, these groups of physicians will hold hospitals accountable to … Continued

RCCA Joins United Healthcare’s Innovative Cancer Care Program to Help Improve Patients’ Access to Quality Treatment

Prnewswire.com HACKENSACK, N.J., Feb. 1, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates LLC (RCCA) is working with United Healthcare to advance a cancer care payment initiative that rewards physicians for focusing on best treatment practices, quality patient care and better health outcomes. The program pays participating medical oncologists more if they demonstrate superior clinical results … Continued

Dr. David Siegel featured in The Wall Street Journal

In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life expectancy for patients with the blood cancer. Dr. Siegel, one of the nation’s foremost authorities on multiple myeloma, shares his thoughts in an article from The Wall Street Journal.

OncLive.com: Bending The Cost Curve

There was a time when biology, chemistry, and a little bit of physics led to dramatic changes in healthcare and healthcare delivery. Legions of physicians, scientists, and other clinical professionals worked over many decades to “move the needle? on combating the diseases that afflict humanity. Lately, however, it appears that this group is not the driving force in effecting change in healthcare delivery. Instead, business and government have done more to “move the needle? in changing healthcare